WeChat-based Chronic Disease Prescriptio

中 · 医疗/养老 · 中型 · 混合 · 通用变现链

WeChat-based Chronic Disease Prescriptio 中 · 医疗/养老 · 中型 · 混合 · 通用变现链 01 / 市场 02 / 产品 03 / 收入 EX / 风险 市场 产品 变现 市场需求 · Pharma… · 市场 › 市场 市场需求 Pharma… 产品交付 · Simpli… · 产品 › 产品 产品交付 Simpli… 收费变现 · 1) Cha… · 收入 › 变现 收费变现 1) Cha… 主要风险 · High t… · 风险 › 变现 主要风险 High t… 切入需求 变现 防范 Legend User UI Agent logic Policy Tool action Context / trace

Strengths

  • • High-frequency WeChat reach, ideal for long-term chronic disease follow-up scenarios
  • • Quantifiable improvements in renewal rates, making it easy to convince pharmacies to purchase

Weaknesses

  • • Reliance on pharmacy staff to execute SOPs, leading to inconsistent implementation quality
  • • Chronic disease data involves privacy concerns, creating high compliance barriers

Opportunities

  • • Accelerating prescription outflows, increasing pharmacy demand for chronic disease retention
  • • Pharmaceutical companies need authentic patient reach and are willing to pay for pharmacy private traffic

Threats

  • • Internet hospitals and O2O platforms are competing for the chronic disease prescription renewal entry point
  • • Pharmacy chains building in-house digital teams may bypass third-party service providers